Edition:
United Kingdom

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

3.16USD
14 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.16
Open
$3.17
Day's High
$3.20
Day's Low
$3.13
Volume
116,235
Avg. Vol
101,010
52-wk High
$3.35
52-wk Low
$2.12

Latest Key Developments (Source: Significant Developments)

Bioscrip Reports Qtrly Loss Per Share $0.14
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - BioScrip Inc ::BIOSCRIP REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 REVENUE $175.8 MILLION VERSUS I/B/E/S VIEW $168.7 MILLION.SEES FY 2018 REVENUE $688 MILLION TO $698 MILLION.QTRLY LOSS PER SHARE $0.14.OPERATIONAL CASH FLOW IS EXPECTED TO RETURN TO MORE NORMALIZED LEVELS BEGINNING IN Q3 OF 2018.IMPLEMENTATION OF ASC 606 WILL NOT IMPACT OPERATING INCOME OR ADJUSTED EBITDA ON A GO-FORWARD BASIS.BIOSCRIP - REAFFIRMING 2018 GUIDANCE FOR REVENUE & ADJUSTED EBITDA.REMAIN INCREASINGLY CONFIDENT THAT CO CAN ACHIEVE AT LEAST $75 MILLION IN ADJUSTED EBITDA IN 2019.Q2 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S.  Full Article

BioScrip Reports Qtrly Loss Per Share Of $0.12
Thursday, 10 May 2018 

May 10 (Reuters) - BioScrip Inc ::BIOSCRIP REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 REVENUE $168.6 MILLION VERSUS I/B/E/S VIEW $165 MILLION.QTRLY LOSS PER SHARE $0.12.  Full Article

BioScrip Provides Update On Immaterial Financial Statement Corrections
Monday, 26 Mar 2018 

March 26 (Reuters) - BioScrip Inc ::BIOSCRIP TIMELY FILES ANNUAL FORM 10-K, CONCLUDES ACCOUNTING REVIEW AND PROVIDES UPDATE ON IMMATERIAL FINANCIAL STATEMENT CORRECTIONS.BIOSCRIP- FY2017 RESULTS REFLECT ANTICIPATED IMMATERIAL CORRECTIONS TO PRELIM FINANCIAL RESULTS REPORTED IN CO'S PRESS RELEASE DATED MARCH 8.  Full Article

BioScrip Announces Additions To Senior Leadership Team
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - BioScrip Inc ::BIOSCRIP ANNOUNCES ADDITIONS TO SENIOR LEADERSHIP TEAM.BIOSCRIP - ‍ANNOUNCED APPOINTMENTS OF HARRIET BOOKER AS CHIEF OPERATING OFFICER, DANNY CLAYCOMB AS SENIOR VICE PRESIDENT, REVENUE CYCLE MANAGEMENT​.  Full Article

Bioscrip reports qtrly ‍loss per share $0.12​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Bioscrip Inc :Bioscrip reports third quarter 2017 financial results.Q3 revenue $198.7 million versus I/B/E/S view $200.9 million.Sees FY 2017 revenue $805 million to $810 million.Bioscrip Inc says ‍updated its adjusted EBITDA guidance to a range of $42.0 million to $44.0 million for full-year 2017​.Bioscrip Inc - Qtrly ‍loss per share $0.12​.Bioscrip Inc sees FY 2017 ‍loss per share in range of $0.58 to $0.64.FY2017 earnings per share view $-0.55, revenue view $824.5 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article